A changing treatment landscape? Current use of biologics in Rheumatology, Gastroenterology and Dermatology Programme
- 01 Oct 2018 to 03 Oct 2018
- 12:01 am - 11:59 pm
- Blended Learning - Online and Live Webinars,
- $395.00 incl. GST for members
- $495.00 incl. GST for non-members
- Save to my calendar
About the event
REGISTRATIONS NOW OPEN!
Biologic drugs are derived from living material and interfere with specific parts of the body’s immune system. Patients with severe immune-mediated inflammatory disease, e.g. rheumatoid arthritis, Crohn’s disease or psoriasis, often respond well and relatively quickly to treatment with biologic medicines.
Dr Rebecca Grainger (Rheumatologist), Dr Stephen Inns (Gastroenterologist) and Dr Gerhard Eichhoff (Dermatologist) will focus on the use of biologics in their specialty areas and cover practical considerations such as specific monitoring, commonly co-prescribed medicines and funding.
Remember this training can be part of your Group 3 learning goal on biologic therapies!
This is a 9 week blended learning Programme starting 1 October 2018. The Programme consists of both online sections and live webinars. You will also have assessments to complete throughout the Programme.
Sponsored By: Novartis New Zealand
Presented By: Dr Rebecca Grainger, Dr Stephen Inns, Dr Gerhard Eichhoff
Rebecca is a Rheumatologist who is employed at the Hutt Valley DHB and a Senior Lecturer at the University of Otago, Department of Medicine. Rebecca’s clinical work focuses on assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout and scleroderma.
Stephen is a Gastroenterologist and General Physician who consults at both Hutt Valley DHB and The Rutherford Clinic. He also works as a Senior Lecturer at the University of Otago, Wellington. His current research interests include the management of quality of life and psychological morbidity in IBD and the effect of Helicobacter pylori on cancer risk and the metabolic syndrome.
Gerhard is a German-trained Dermatologist who has worked as a Consultant Dermatologist in New Zealand since early 2017. He is employed by CCDHB and runs clinics at Wellington, Kenepuru and Hutt Hospitals. Before moving to New Zealand he worked at the Technical University of Munich where he treated patients with the newest biologics including Ustekinumab and Secukinumab.
Live webinar times and dates:
It is estimated that the live trainings will be approximately 90 – 120 minutes each.
- Wednesday 17 October 2018 from 7.30pm – 9.30pm
- Wednesday 31 October 2018 from 7.30pm – 9.30pm
- Wednesday 14 November 2018 from 7.30pm - 9.30pm
On completion of all activities, participants will be able to:
- Explain what biologic medicines are
- Recognise the current main indications for these biologics in immune-mediate inflammatory disease (IMID)
- Describe the mechanism of action of biologics in IMID and explain the main adverse effects and contra-indications
- Describe monitoring considerations for patients on biologics for IMID
- Discuss factors that should be considered prior to initiation of treatment with biologics in IMID
Pharmacists must achieve a pass mark in all assessments in order to attain completion. Marking will commence after the closing date for assignments and completion advised thereafter (as these require manual marking).
Once completed a Certificate of Completion of the Programme will be available.
One learning package must be purchased for each individual.
Group 1: To be confirmed Group 2: To be confirmed
Note: Readings are not assessed. You may allocate 1 Group 1 point per hour of learning for readings.
Non Member Registration
Non PSNZ members can register for this event. Please note you will need to register as a user on the PSNZ website before you can register to attend the event. Look for the "New user? Register now" option at the bottom of the Login screen.
Cancellation and Refund Policy:
Payment must be received before your registration is processed. Instructions on how to access this course will be emailed to your preferred email address once your registration is processed.
Access to this online course will expire six months after payment is received.
By enrolling in this training, you are confirming that all work undertaken within this training programme and assessment answers are your own. If there are grounds to believe that cheating or plagiarism has occurred, we will investigate and your work may be disallowed and you will be unable to complete the training.